Oruka Therapeutics(us:ORKA)

9.56

-6.82%

Updated on 2025-04-02

Open:10.19
Close:9.56
High:10.29
Low:8.95
Prev Close:10.26
Volume:705199.00
Turnover:6.75M
Turnover Ratio:1.88%
Shares:37.44M
MarketCap:357.93M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-303610766267.42%1448
2024-03-3127719889049.64%259
2023-12-3126747732051.56%575
2023-09-3025325775822.61%3411
2023-06-3028282931619.63%3212
2023-03-3126252178017.50%594
2022-12-3127261292818.13%389
2022-09-3027222202315.42%458
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Perceptive Advisors Llc15507760106.90%15507760
2024-06-30Driehaus Capital Management Llc384615026.51%3846150
2024-06-30Cable Car Capital Llc3333582.30%0
2024-06-30Rtw Investments, Lp1166620.80%116662
2024-06-30Janus Henderson Group Plc1152230.79%115223
2024-06-30Adage Capital Partners Gp, L.L.C.999960.69%99996
2024-06-30Avidity Partners Management Lp833300.57%83330
2024-06-30Vr Adviser, Llc721950.50%72195
2024-06-30Cowen And Company, Llc583310.40%58331
2024-06-30Morgan Stanley541650.37%54165

About

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Address:10170 Church Ranch Way,Suite 100

Market Movers